Ergoteles LLC Cerus Corp Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $720,207 - $899,193	-213,079 Reduced 92.53%	17,199 $62,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $789,853 - $1.34 Million	230,278 New	230,278 $829,000
Q2 2022 Aug 12, 2022	SELL	$4.41 - $5.69 $148,087 - $191,070	-33,580 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.81 - $6.99 $161,519 - $234,724	33,580 New	33,580 $184,000
Q3 2021 Nov 15, 2021	SELL	$4.79 - $6.68 $53,169 - $74,148	-11,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.35 - $6.35 $59,384 - $70,485	11,100 New	11,100 $66,000
Q1 2021 May 12, 2021	SELL	$5.68 - $7.87 $498,704 - $690,986	-87,800 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.25 - $8.56 $460,950 - $751,568	87,800 New	87,800 $608,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.